{"id":"NCT02953340","sponsor":"Spectrum Pharmaceuticals, Inc","briefTitle":"SPI-2012 vs Pegfilgrastim in Management of Neutropenia in Breast Cancer Participants With Docetaxel and Cyclophosphamide","officialTitle":"Randomized, OpEn-Label, Active-ContrOl Trial of SPI-2012 (Eflapegrastim) Versus Pegfilgrastim in the Management of Chemotherapy-Induced Neutropenia in Early-Stage BReast Cancer Patients Receiving Docetaxel and Cyclophosphamide (TC) (RECOVER)","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2017-05-10","primaryCompletion":"2018-06-08","completion":"2019-05-06","firstPosted":"2016-11-02","resultsPosted":"2022-03-02","lastUpdate":"2022-03-02"},"enrollment":237,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Neutropenia","Breast Cancer"],"interventions":[{"type":"DRUG","name":"SPI-2012","otherNames":["HM10460A","Rolontis®","Eflapegrastim"]},{"type":"DRUG","name":"Pegfilgrastim","otherNames":["Neulasta®"]},{"type":"DRUG","name":"Docetaxel","otherNames":["Taxotere"]},{"type":"DRUG","name":"Cyclophosphamide","otherNames":["Cytoxan"]}],"arms":[{"label":"(Arm 1): SPI-2012 and TC","type":"EXPERIMENTAL"},{"label":"(Arm 2): Pegfilgrastim and TC","type":"EXPERIMENTAL"}],"summary":"The purpose of this study is to compare the efficacy of SPI-2012 versus pegfilgrastim in participants with early-stage breast cancer receiving docetaxel and cyclophosphamide (TC) as measured by the duration of severe neutropenia (DSN).","primaryOutcome":{"measure":"Duration of Severe Neutropenia (DSN) in Cycle 1","timeFrame":"Day 1 and daily on Days 4-15 in Cycle 1 (each cycle = 21 days)","effectByArm":[{"arm":"(Arm 1): SPI-2012 and TC","deltaMin":0.31,"sd":0.688},{"arm":"(Arm 2): Pegfilgrastim and TC","deltaMin":0.39,"sd":0.949}],"pValues":[{"comp":"OG000 vs OG001","p":"< 0.0001"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":10,"exclusionCount":9},"locations":{"siteCount":74,"countries":["United States","Canada","Hungary","India","Poland","South Korea"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":12,"n":117},"commonTop":["Nausea","Bone pain","Lymphocyte count decreased","Fatigue","Alopecia"]}}